Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Medicine (Baltimore) ; 101(8): e28803, 2022 Feb 25.
Article in English | MEDLINE | ID: mdl-35212274

ABSTRACT

ABSTRACT: To assess the clinical efficacy and safety of gelatin sponge microparticles-transcatheter arterial chemoembolization (GSMs-TACE) plus synchronous antigen-presenting dendritic cell (DC) sequential reinfusion for advanced large liver cancer (LC).Patients with large LC were assigned to the experimental (combined sequential DC therapy) or control group. All patients received standardized GSMs-TACE. In the experimental group, 60 mL of peripheral blood was collected for in vitro culture of DCs (10-14 days). Then, intravenous reinfusion was conducted 3 times within 10, 20, and 30 days after surgery. Adverse reactions during the treatment were recorded and evaluated. The overall survival, transcatheter arterial chemoembolization frequency, and physical score (PS) were calculated.The median survival time of the experimental group was significantly longer than that of the control group. There were significant differences in median progression-free survival between the 2 groups (P < .05) and the objective effective rate at 1 and 6 months and 1 year (P < .05), but not 2 years (P > .05). The PSs of 2 groups were significantly improved at 1 month after GSMs-TACE, with more obvious improvement in the experimental group (P < .05).GSMs-TACE plus synchronous DC sequential reinfusion significantly prolonged the median survival time, improved the tumor response rate and PS, prolonged progression-free survival, and reduced intervention frequency. GSMs-TACE plus synchronous DC sequential reinfusion treatment is suitable for comprehensive treatment of patients with advanced larger LC in China.


Subject(s)
Carcinoma, Hepatocellular/therapy , Chemoembolization, Therapeutic , Dendritic Cells , Immunotherapy , Liver Neoplasms/therapy , Aged , Carcinoma, Hepatocellular/pathology , Chemoembolization, Therapeutic/adverse effects , Combined Modality Therapy , Dendritic Cells/pathology , Female , Gelatin/adverse effects , Hepatomegaly/etiology , Humans , Liver Neoplasms/pathology , Male , Middle Aged , Prospective Studies , Treatment Outcome
2.
Proc Natl Acad Sci U S A ; 116(44): 22347-22352, 2019 10 29.
Article in English | MEDLINE | ID: mdl-31611410

ABSTRACT

Observing the structure and regeneration of the myelin sheath in peripheral nerves following injury and during repair would help in understanding the pathogenesis and treatment of neurological diseases caused by an abnormal myelin sheath. In the present study, transmission electron microscopy, immunofluorescence staining, and transcriptome analyses were used to investigate the structure and regeneration of the myelin sheath after end-to-end anastomosis, autologous nerve transplantation, and nerve tube transplantation in a rat model of sciatic nerve injury, with normal optic nerve, oculomotor nerve, sciatic nerve, and Schwann cells used as controls. The results suggested that the double-bilayer was the structural unit that constituted the myelin sheath. The major feature during regeneration was the compaction of the myelin sheath, wherein the distance between the 2 layers of cell membrane in the double-bilayer became shorter and the adjacent double-bilayers tightly closed together and formed the major dense line. The expression level of myelin basic protein was positively correlated with the formation of the major dense line, and the compacted myelin sheath could not be formed without the anchoring of the lipophilin particles to the myelin sheath.


Subject(s)
Myelin Sheath/ultrastructure , Nerve Regeneration , Peripheral Nerve Injuries/metabolism , Animals , Axons/metabolism , Axons/ultrastructure , Myelin Sheath/metabolism , Peripheral Nerve Injuries/pathology , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...